These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15722065

  • 1. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F.
    Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
    [Abstract] [Full Text] [Related]

  • 2. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.
    Beksinska ME, Kleinschmidt I, Smit JA, Farley TM.
    Contraception; 2007 Jun; 75(6):438-43. PubMed ID: 17519149
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S, Ekmahachai M, Chaovisitsaree S, Suntornlimsiri N, Morakote N.
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P, Bottazzi M, Steel SA.
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [Abstract] [Full Text] [Related]

  • 6. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status.
    Beksinska ME, Kleinschmidt I, Smit JA.
    Womens Midlife Health; 2018 May; 4():6. PubMed ID: 30766716
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
    Beksinska ME, Kleinschmidt I, Smit JA, Farley TM.
    Contraception; 2009 May; 79(5):345-9. PubMed ID: 19341845
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
    Bahamondes L, Juliato CT, Villarreal M, Sobreira-Lima B, Simões JA, dos Santos Fernandes AM.
    Contraception; 2006 Sep; 74(3):259-63. PubMed ID: 16904421
    [Abstract] [Full Text] [Related]

  • 11. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 12. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
    [Abstract] [Full Text] [Related]

  • 13. Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
    Beksinska ME, Smit JA, Kleinschmidt I, Farley TM.
    S Afr Med J; 2011 Feb; 101(2):131-5. PubMed ID: 21678742
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density in adolescent females using depot medroxyprogesterone acetate.
    Lara-Torre E, Edwards CP, Perlman S, Hertweck SP.
    J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):17-21. PubMed ID: 15010034
    [Abstract] [Full Text] [Related]

  • 15. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 16. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L, Landgren BM, Lindberg UB, Silfverstolpe G, Crona N.
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P.
    Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
    [Abstract] [Full Text] [Related]

  • 18. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
    [Abstract] [Full Text] [Related]

  • 19. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Viola AS, Castro S, Marchi NM, Bahamondes MV, Viola CF, Bahamondes L.
    Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
    [Abstract] [Full Text] [Related]

  • 20. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM, Martins WP, Vieira CS, Soares GM, Franceschini SA, Ferriani RA, Patta MC.
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.